Repurchase of shares in AstraZeneca PLC

REPURCHASE OF SHARES IN ASTRAZENECA PLC AstraZeneca PLC announces that on 5 June 2000, it purchased for cancellation 570,000 ordinary shares of AstraZeneca PLC at a price of 2747 pence per share. Upon the cancellation of these shares, the number of shares in issue will be 1,768,516,843 G H R Musker Company Secretary 6 June 2000 ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/06/06/20000606BIT00080/bit0001.doc http://www.bit.se/bitonline/2000/06/06/20000606BIT00080/bit0002.pdf

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com

Subscribe